EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort

Robert W Corty iD, James Brogan, Kevin Byram, Jason Springer, Peter C Grayson iD, Alexander G Bick iD

Arthritis & Rheumatology · 2024-06 · 76 (6) · 942-948

DOI: 10.1002/art.42802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 29.02.2024. Verfasst von Robert W Corty und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Autoimmune Diseases, Ubiquitin-Activating Enzymes. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIH Office of the Director, Pew Charitable Trusts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Somatic variants in UBA1 cause VEXAS, a recently described, systemic autoinflammatory disease. Research on VEXAS has largely focused on highly symptomatic patients. We sought to determine the prevalence of canonical, VEXAS‐associated somatic variants and their disease penetrance in a diverse, unselected population.

Methods

We analyzed clinical‐grade whole genome sequencing data from 245,368 participants in the All of Us Research Program. We compared persons carrying a canonical VEXAS‐associated somatic variant to age, sex, and ancestry matched controls across the domains of diagnoses, medications, and laboratory values.

Results

74 participants were identified who carry one VEXAS‐defining somatic variant, UBA1 c.121A>C, p.Met41Leu. The variant allele fraction ranged from 4.5% to 33%. No other canonical VEXAS‐associated variants were identified. Of the 74 carriers, 62 (84%) were women, 20 (27%) were African American, and 14 (19%) were American Admixed/Latino. There was no statistically significant association between case/control status and any VEXAS‐associated diagnosis code, medication prescription, or laboratory value.

Conclusion

We report the largest cohort to date of persons with the VEXAS‐associated p.Met41Leu somatic variant. This cohort differed substantially from reported cohorts of patients with clinical VEXAS, having a higher proportion of persons who were young, female, and of diverse ancestry. Variant allele fractions were lower than reported in clinical VEXAS cohorts, and bioinformatic analysis detected no clinical manifestations of VEXAS. Thus, the UBA1 p.Met41Leu somatic variant displayed incomplete penetrance for VEXAS. Further study is needed to determine the natural history of VEXAS‐associated somatic variants in the predisease phase. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesUbiquitin-Activating EnzymesCohort StudiesUnited StatesWhole Genome SequencingFemaleHumansAdultSkin Diseases, GeneticMaleYoung AdultHispanic or LatinoAdolescentPenetranceMyelodysplastic SyndromesGenetic VariationBlack or African AmericanMiddle Aged

Substanzen

UBA1 protein, humanUbiquitin-Activating Enzymes

Autor:innen und Institutionen

  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.

ORCID-Profile: Robert W Corty, Peter C Grayson, Alexander G Bick

Förderung

  • NIH HHS
  • NIH Office of the Director
  • Pew Charitable Trusts
  • Burroughs Wellcome Fund
  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Corty, R. W., Brogan, J., Byram, K., Springer, J., Grayson, P. C., & Bick, A. G. (2024). VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort. Arthritis & Rheumatology, 76(6), 942-948. https://doi.org/10.1002/art.42802

Vancouver

Corty RW, Brogan J, Byram K, Springer J, Grayson PC, Bick AG. VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort. Arthritis & Rheumatology. 2024;76(6):942-948. doi:10.1002/art.42802

BibTeX
@article{Corty2024,
  author = {Corty, Robert W and Brogan, James and Byram, Kevin and Springer, Jason and Grayson, Peter C and Bick, Alexander G},
  title = {VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  volume = {76},
  number = {6},
  pages = {942--948},
  doi = {10.1002/art.42802}
}
Kostenlos starten →